Decreased post operative analgesic requirements and side effects of patient-controlled intravenous analgesia after paravertebral lamina technique for breast cancer surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001151

Enrollment

Registered

2014-07-03

Start date

2013-09-10

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The patients was randomly assigned to two groups (Group C: PCA only, Group P: US-guided retrolaminar paravertebral block with PCA). In group P, Ultrasound-guided paravertebral lami

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 18-75 years old women patients with American Society of Anesthesiologists physical status (ASA) I to II who were scheduled for elective unilateral breast tumor resection

Exclusion criteria

Exclusion criteria: Exclusion criteria included contraindications to PVBs such as coagulopathy, infection at injection site; history of allergy to local anesthetics, morphine, pregnancy; breast feeding; severe obesity (body mass index greater than 35 kg/m2); major psychosis; drug and alcohol abuse; chronic pain or long-term analgesic usage; and history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal, or hepatic disease; language barrier.

Design outcomes

Primary

Measure	Time frame
cumulative opioid consumption for postoperative 24 h	—

Secondary

Measure	Time frame
Visual Analogue Scale (VAS) at rest;Visual Analogue Scale (VAS) during coughing;Incidence of nausea;Incidence of vomiting;Incidence of hypotension;Incidence of dyspnea;Incidence of local anesthetic toxicity;Incidence of Horner's syndrome;Satisfaction on postoperative pain management	—

Countries

Korea, Republic of

Contacts

Public ContactEunsoo Kim

Pusan National University Hospital

Outcome results